Docrates Cancer Center

Docrates Cancer Center is a private, specialized oncology hospital based in Helsinki, Finland, dedicated to the diagnosis, treatment, and monitoring of cancer. Established in 2007, the center is recognized as a pioneer in precision medicine and radiopharmaceutical therapies, particularly for advanced prostate cancer. It offers a comprehensive suite of services, including state-of-the-art imaging, radiotherapy, isotope treatments, and systemic therapies like immunotherapy and targeted drugs. The facility is known for its international reach, treating patients from over 60 countries with a focus on rapid treatment initiation and personalized care plans. In 2024, Docrates was acquired by Mehiläinen, a leading Finnish healthcare provider, to strengthen its oncology service portfolio.